Delivery Order SPE2DB22D3301-SPE2DB25FX4FW
Award Date
10/23/24
Potential Completion Date
11/14/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,421.17 firm fixed-price delivery order is for the supply of 4566745148 INLYTA 5 MG TABLET 60S, with a performance period ending on January 9, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,421.17, is for the delivery of 4566912303 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is February 4, 2025. This award is associated with a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,421.17 firm fixed-price delivery order is for the supply of 4567363305 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $22,079.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of INLYTA 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 16, 2024. This award is a firm fixed price delivery order and does not have a set-aside designation. In addition to this specific delivery order,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,369.36 firm fixed-price delivery order contract covers the supply of Inlyta 5 mg tablets, a medication used to treat advanced renal cell carcinoma. The contract has an ultimate completion date of December 13, 2024 and was awarded on November 21, 2024. This award is associated with a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,079.24, is for the delivery of 4566135586 - INLYTA 5 MG TABLET 60S. It is a firm fixed-price delivery order contract with a completion date of November 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $11,458.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INLYTA 1 MG TABLET 180S, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of March 17, 2025. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $22,115.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 20, 2024. The contract covers the provision of INLYTA 1 MG TABLET 180S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6GAY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $22,916.36 firm fixed-price delivery order is for the pharmaceutical product INLYTA 1 MG TABLET 180S. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $22,079.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564598972 INLYTA 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2024 and was awarded on May 14, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds...